Top 5 Biotech Stocks To Invest In Right Now

Top 5 Biotech Stocks To Invest In Right Now: Johnson & Johnson(JNJ)

Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment provides products used in baby care, skin care, oral care, wound care, and women?s health care fields, as well as nutritional, over-the-counter pharmaceutical products, and wellness and prevention platforms under the brands of JOHNSON?S, AVEENO, CLEAN & CLEAR, JOHNSON?S Adult, NEUTROGENA, RoC, LUBRIDERM, DABAO, LISTERINE, REACH, BAND-AID, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC. The Pharmaceutical segment offers products in various therapeutic areas, such as anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, and virology. Its principal products include REMICADE for the treatment of immune me diated inflammatory diseases; STELARA for the treatment of moderate to severe plaque psoriasis; SIMPONI, a treatment for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis; VELCADE for the treatment of multiple myeloma; PREZISTA and INTELENCE for treating HIV/AIDS patients; NUCYNTA for moderate to severe acute pain; INVEGA SUSTENNAtm for the acute and maintenance treatment of schizophrenia in adults; RISPERDAL CONSTA for the management of bipolar I disorder and schizophrenia; and PROCRIT to stimulate red blood cell production. The Medical Devices and Diagnostics segment primarily offers circulatory disease management products; orthopaedic joint reconstruction, spinal care, and sports medicine products; surgical care, aesthetics, and women?s health products; blood glucose monitoring and insulin delivery products; professional diagnostic products; and disposable contact lenses. The company was founded in! 1886 and is based in N e w Brunswick, New Jersey.

Advisors' Opinion:

• [By Maxx Chatsko]

  There may never be a chemical cure for autism, but atypical antipsychotic medications are the best current option for alleviating behavioral symptoms associated with the spectrum disorder. The problem is that they blanket dopamine and serotonin pathways to do so, which comes with a fair share of unintended side effects. Johnson & Johnson (NYSE: JNJ  ) markets Risperdal, Eli Lilly (NYSE: LLY  ) markets Zyprexa, and Bristol-Myers Squibb (NYSE: BMY  ) markets Abilify Each treatment does mark an improvement over first generation drugs called typical antipsychotics. Unfortunately, we can do much better. Perhaps BigBrain and a flurry of generic competition facing each medication will lead to big advances for autistic individuals.

• [By Dan Caplinger]

  Johnson & Johnson (NYSE: JNJ  ) has posted gains of about 1.3% a day after the FDA gave its simeprevir hepatitis-C drug priority review status. The hep-C market has been a hotbed of activity lately, and the FDA move will help J&J to remain an important player in the niche and to potentially get a much faster approval process than would be available otherwise.

• [By Keith Speights]

  Rogaine
  First introduced back in 1988 by Upjohn, Rogaine is the granddaddy of male pattern baldness drugs. Johnson & Johnson (NYSE: JNJ  ) acquired rights to the product in 2006 and soon afterward launched Rogaine Foam. After all these years, Rogaine still stands as the most recommended brand for hair regrowth by dermatologists.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-5-biotech-stocks-to-invest-in-right-now.html